According to Regeneron Pharmaceuticals's latest financial reports the company's current earnings (TTM) are S$5.97 B. In 2023 the company made an earning of S$5.46 B a decrease over its 2022 earnings that were of S$6.32 B.The earnings displayed on this page is the company's Pretax Income.